Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis

Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis

Abstract Alcoholic hepatitis (AH) is a life-threatening condition characterized by profound hepatocellular dysfunction for which targeted treatments are urgently needed. Identification of molecular drivers is hampered by the lack of suitable animal models. By performing RNA sequencing in livers from...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autori principali:	Josepmaria Argemí, María U. Latasa, Stephen R. Atkinson, Ilya O. Blokhin, Veronica Massey, Joel P. Gue, Joaquín Cabezas, Juan José Lozano, Derek Van Booven, Aaron Bell, Sheng Cao, Lawrence A. Vernetti, Juan Pablo Arab, Meritxell Ventura‐Cots, Lia R. Edmunds, Constantino Fondevila, Peter Stärkel, Laurent Dubuquoy, Alexandre Louvet, Gemma Òdena, Juan L. Gómez, Tomás Aragón, José Altamirano, Juan Caballería, Michael J. Jurczak, D. Lansing Taylor, Carmen Berasain, Claes Wahlestedt, Satdarshan P. Monga, Marsha Y. Morgan, Pau Sancho‐Bru, Philippe Mathurin, Shinji Furuya, Carolin Lackner, Ivan Rusyn, Vijay H. Shah, Mark Thursz, Jelena Mann, Matías A. Ávila, Ramón Bataller
Natura:	Artigo
Lingua:	inglese
Pubblicazione:	2019
Accesso online:	https://doi.org/10.1038/s41467-019-11004-3 https://www.nature.com/articles/s41467-019-11004-3.pdf
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis
di: Argemi, Josepmaria, et al.
Pubblicazione: (2019)

Hepatic lipocalin 2 promotes liver fibrosis and portal hypertension
di: Chen, Jiegen, et al.
Pubblicazione: (2020)

Identifying New Epigenetic Drivers of Liver Fibrosis
di: Argemi, Josepmaria, et al.
Pubblicazione: (2018)

Hepatocyte–stellate cell synapse in alcohol-induced steatosis: another role for endocannabinoids
di: Argemi, Josepmaria, et al.
Pubblicazione: (2020)

Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic Hepatitis
di: Massey, Veronica, et al.
Pubblicazione: (2020)

Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic Hepatitis
di: Veronica Massey, et al.
Pubblicazione: (2020)

Hepatocyte-derived macrophage migration inhibitory factor mediates alcohol-induced liver injury in mice and patients
di: Marin, Veronica, et al.
Pubblicazione: (2017)

Systemic Inflammatory Response and Serum Lipopolysaccharide Levels Predict Multiple Organ Failure and Death in Alcoholic Hepatitis
di: Michelena, Javier, et al.
Pubblicazione: (2015)

Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis
di: Javier Michelena, et al.
Pubblicazione: (2015)

Hepatocyte-derived macrophage migration inhibitory factor mediates alcohol-induced liver injury in mice and patients
di: V. Marin, et al.
Pubblicazione: (2017)

A novel mouse model of acute-on-chronic cholestatic alcoholic liver disease: A systems biology comparison with human alcoholic hepatitis
di: Furuya, Shinji, et al.
Pubblicazione: (2019)

Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis
di: Brandl, Katharina, et al.
Pubblicazione: (2018)

Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis
di: Katharina Brandl, et al.
Pubblicazione: (2018)

Serum Acylcarnitines Associated with High Short-Term Mortality in Patients with Alcoholic Hepatitis
di: Gao, Bei, et al.
Pubblicazione: (2021)

Loss of hepatocyte identity following aberrant YAP activation: A key mechanism in alcoholic hepatitis
di: Mohamed Bou Saleh, et al.
Pubblicazione: (2021)

Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis
di: Lang, Sonja, et al.
Pubblicazione: (2019)

Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis
di: Sonja Lang, et al.
Pubblicazione: (2019)

Alcoholic Hepatitis
di: Gougol, Amir, et al.
Pubblicazione: (2021)

Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis
di: Pau Sancho‐Bru, et al.
Pubblicazione: (2012)

Ductular Reaction Cells Display an Inflammatory Profile and Recruit Neutrophils in Alcoholic Hepatitis
di: Aguilar-Bravo, Beatriz, et al.
Pubblicazione: (2019)

Ductular Reaction Cells Display an Inflammatory Profile and Recruit Neutrophils in Alcoholic Hepatitis
di: Beatriz Aguilar‐Bravo, et al.
Pubblicazione: (2018)

Loss of liver function in chronic liver disease: An identity crisis
di: Carmen Berasain, et al.
Pubblicazione: (2022)

Perturbations in mitochondrial dynamics are closely involved in the progression of Alcoholic Liver Disease.
di: Palma, Elena, et al.
Pubblicazione: (2020)

TLR7‐let‐7 Signaling Contributes to Ethanol‐Induced Hepatic Inflammatory Response in Mice and in Alcoholic Hepatitis
di: Massey, Veronica L., et al.
Pubblicazione: (2018)

Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases
di: Guldiken, Nurdan, et al.
Pubblicazione: (2021)

Peroxisome Proliferator-Activated Receptors in HBV-Related Infection
di: Dubuquoy, Laurent, et al.
Pubblicazione: (2009)

Deficient IL‐6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and Fibrosis
di: Stärkel, Peter, et al.
Pubblicazione: (2019)

LPS-TLR4 Pathway Mediates Ductular Cell Expansion in Alcoholic Hepatitis
di: Odena, Gemma, et al.
Pubblicazione: (2016)

Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming
di: Beatriz Aguilar‐Bravo, et al.
Pubblicazione: (2023)

Exogenous Liposomal Ceramide-C6 Ameliorates Lipidomic Profile, Energy Homeostasis, and Anti-Oxidant Systems in NASH
di: Zanieri, Francesca, et al.
Pubblicazione: (2020)

Kinase analysis in alcoholic hepatitis identifies p90RSK as a potential mediator of liver fibrogenesis
di: Morales-Ibanez, Oriol, et al.
Pubblicazione: (2015)

Reduced Serum Sphingolipids Constitute a Molecular Signature of Malnutrition in Hospitalized Patients With Decompensated Cirrhosis
di: Rachakonda, Vikrant, et al.
Pubblicazione: (2019)

Intestinal virome in patients with alcoholic hepatitis
di: Jiang, Lu, et al.
Pubblicazione: (2020)

Intestinal Virome in Patients With Alcoholic Hepatitis
di: Lu Jiang, et al.
Pubblicazione: (2020)

Myeloid Endoplasmic Reticulum Resident Chaperone GP96 Facilitates Inflammation and Steatosis in Alcohol‐Associated Liver Disease
di: Ratna, Anuradha, et al.
Pubblicazione: (2021)

504. Case SEries: Nasal Antimicrobial Photodisinfection (APDT) as Treatment Protocol for Asymptomatic and Early Stage COVID-19 Patients
di: Kolenda, Jack, et al.
Pubblicazione: (2021)

Clinical, histological and molecular profiling of different stages of alcohol-related liver disease
di: Meritxell Ventura‐Cots, et al.
Pubblicazione: (2022)

Alcohol-Associated Liver Disease: Integrated Management With Alcohol Use Disorder
di: Juan Pablo Arab, et al.
Pubblicazione: (2023)

Bariatric Surgery Is Associated with Alcohol-Related Liver Disease and Psychiatric Disorders Associated with AUD
di: Edilmar Alvarado‐Tápias, et al.
Pubblicazione: (2023)

Pre-clinical and clinical investigations of metabolic zonation in liver diseases: The potential of microphysiology systems
di: Alejandro Soto–Gutiérrez, et al.
Pubblicazione: (2017)